Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
NCT07398326
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
anlotinib and sintilimab
Sponsor
Shanghai Changzheng Hospital